Pharmaceutical Technology on MSN9h
FDA approves AstraZeneca FluMist ‘flu vaccine for self-administration
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
The American Journal of Managed Care3h
FDA Approves First Self-Administered Nasal Spray Flu Vaccine
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
Yahoo4h
FDA approves at-home flu vaccine nasal spray. Here's what to know about it.
FluMist was produced by the AstraZeneca company. The FDA stated in a release on Friday, "FluMist is approved for the ...
WebMD21h
FDA Approves First At-Home Nasal Flu Vaccine
According to MedImmune, the AstraZeneca subsidiary that makes FluMist, studies have shown that people ages 18 to 49 can successfully give the vaccine, and it's just as effective as having a doctor or ...
At-home flu vaccine authorized by FDA
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...
CNET12m
An At-Home Flu Vaccine? It'll Be Available Next Year
FluMist won't be available until next year, according to the website for FluMist, which is owned by AstraZeneca. Once it does ...
Nasal spray flu vaccine gets FDA approval for home use: ‘A good alternative’
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver. Dr. Nicole Saphier and Dr. Marc Siegel weigh in.
WXYZ1h
First self-administered, at-home flu vaccine receives FDA approval
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...
Latest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails To Extend Lives Of Pretreated Breast Cancer Patients
AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...
ConsumerAffairs55m
FDA approves first at-home nasal spray flu vaccine for the 2-49 age range
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
CBS News on MSN3h
When should you get the flu shot? A doctor weighs in on best timing, options.
The FluMist vaccine, manufactured by AstraZeneca, was approved in 2003 for health care providers to give patients, but the method has gotten renewed attention due to a new, broader approval. On Friday ...
Pharmabiz17h
US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration
US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration: Cambridge, UK Monday, September 23, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science- ...